According to Zacks, “Nu Skin, which has outdone the industry in the past month, has been steadily gaining from solid performance across most regional units and sustained growth in customer count. These upsides and enhanced margins fueled first-quarter 2019 results, wherein top and bottom lines grew year over year and surpassed estimates. Further, the company’s focus on expanding global beauty device systems and optimizing the Velocity program bodes well. This is reflected in management’s outlook for 2019. However, the company issued a soft view for the second quarter, which is likely to be hurt by tough year-over-year comparisons related to LumiSpa. Moreover, currency headwinds are expected to persist, and hurt sales growth by 4-5% and 2-3% in the second quarter and 2019, respectively. Competition from cheaper alternatives is certainly a threat as well.”
A number of other research analysts have also weighed in on the stock. ValuEngine raised shares of Nu Skin Enterprises from a sell rating to a hold rating in a research report on Wednesday, May 1st. Bank of America reissued an underperform rating and set a $57.00 price target (up from $52.00) on shares of Nu Skin Enterprises in a research report on Wednesday, May 1st. Deutsche Bank raised shares of Nu Skin Enterprises from a hold rating to a buy rating and set a $60.00 price objective on the stock in a research report on Wednesday, May 1st. Stifel Nicolaus lowered shares of Nu Skin Enterprises from a hold rating to a sell rating and lowered their price objective for the stock from $63.00 to $43.00 in a research report on Monday, March 25th. Finally, Pivotal Research reaffirmed a buy rating and issued a $85.00 price objective on shares of Nu Skin Enterprises in a research report on Wednesday, March 13th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the stock. Nu Skin Enterprises has an average rating of Hold and an average target price of $73.75.
NUS opened at $57.96 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.15 and a current ratio of 1.86. Nu Skin Enterprises has a fifty-two week low of $44.36 and a fifty-two week high of $88.68. The stock has a market cap of $3.24 billion, a P/E ratio of 16.47, a PEG ratio of 1.34 and a beta of 0.67.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Tuesday, April 30th. The company reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.06. Nu Skin Enterprises had a net margin of 4.82% and a return on equity of 26.81%. The company had revenue of $623.60 million for the quarter, compared to analyst estimates of $615.98 million. During the same period last year, the firm earned $0.79 earnings per share. The firm’s revenue was up 1.2% on a year-over-year basis. Equities research analysts predict that Nu Skin Enterprises will post 3.92 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Friday, May 31st will be given a $0.37 dividend. This represents a $1.48 annualized dividend and a yield of 2.55%. The ex-dividend date of this dividend is Thursday, May 30th. Nu Skin Enterprises’s dividend payout ratio is 42.05%.
A number of hedge funds have recently made changes to their positions in the business. BlackRock Inc. raised its position in Nu Skin Enterprises by 3.4% in the fourth quarter. BlackRock Inc. now owns 6,273,298 shares of the company’s stock worth $384,741,000 after acquiring an additional 205,481 shares during the period. Dimensional Fund Advisors LP raised its position in Nu Skin Enterprises by 3.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,132,318 shares of the company’s stock worth $69,442,000 after acquiring an additional 38,282 shares during the period. Norges Bank bought a new stake in Nu Skin Enterprises in the fourth quarter worth about $56,136,000. Bank of New York Mellon Corp raised its position in Nu Skin Enterprises by 0.4% in the third quarter. Bank of New York Mellon Corp now owns 820,216 shares of the company’s stock worth $67,601,000 after acquiring an additional 3,213 shares during the period. Finally, MERIAN GLOBAL INVESTORS UK Ltd increased its stake in shares of Nu Skin Enterprises by 8.9% in the fourth quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 813,238 shares of the company’s stock worth $49,875,000 after purchasing an additional 66,408 shares in the last quarter. 75.92% of the stock is currently owned by institutional investors and hedge funds.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Featured Story: What is a Futures Contract?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.